Snowball logo
logo
PRM

Big Pharma Split Corp Class A

PRM โ€ข TO
CA$15.01CA$0.00ย  (0%)
Estimate
EPS
-1.95
Beta
0.732
Growth
Revenue, YoY
250.49%
Net income, YoY
50.96%
FCF, YoY
237.01%
Dividends
Dividend yield
8.24%
Annual payout
CA$1.24
Next ex. div date
October 30, 26
Payout
81.08%
Div.rating
About the company
Ticker
PRM
ISIN
CA08934P1080
Country
Canada
Sector (GICS)
Financials
Big Pharma Split Corp is a closed ended equity mutual fund launched and managed by Harvest Portfolios Group Inc. It invests in the public equity markets across United States. The fund primarily invests in the Pharmaceutical sector. Big Pharma Split Corp was formed on September 15, 2017 and is domiciled in Canada.

Frequently asked questions

What sector does Big Pharma Split Corp Class A (PRM) operate in?

Big Pharma Split Corp Class A belongs to the Financials sector and operates in the Asset Management industry.

What is Big Pharma Split Corp Class A (PRM) current stock price?

As of the latest data, Big Pharma Split Corp Class A stock price is CA$15.01, with a previous close of CA$15.01.

What is Big Pharma Split Corp Class A (PRM) current market capitalization?

Big Pharma Split Corp Class A market cap is approximately 19.71 million.

What is Big Pharma Split Corp Class A (PRM) Earnings Per Share (EPS)?

The trailing EPS is -CA$1.95.

Does Big Pharma Split Corp Class A (PRM) pay dividends?

Yes. Big Pharma Split Corp Class A pays monthly dividends with an annualized yield of 8.24% and an estimated annual payout of CA$1.24 per share.

When is the next ex-dividend date for Big Pharma Split Corp Class A (PRM)?

The next ex-dividend date is scheduled for October 30, 2026.

What is Big Pharma Split Corp Class A (PRM) beta (volatility) score?

Big Pharma Split Corp Class A has a beta of 0.732, indicating lower volatility than the overall market.